ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type
GSE81380	28249907	C-21	None	SRX1758035	GSE81380	C-21	GSM2151452	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-21	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-21	Breast Cancer
GSE81380	28249907	C-29	None	SRX1758036	GSE81380	C-29	GSM2151453	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-29	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-29	Breast Cancer
GSE81380	28249907	C-3	None	SRX1758037	GSE81380	C-3	GSM2151454	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-3	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-3	Breast Cancer
GSE81380	28249907	C-6	None	SRX1758038	GSE81380	C-6	GSM2151455	Breast Cancer	Invasive Breast Carcinoma (BRCA)	C-6	AU565(pv) tumour bearing SCID mice treated with Vehicle (D5W days 0,1; PBS days 0)	Mus musculus	C-6	Breast Cancer
GSE81380	28249907	E-12	None	SRX1758039	GSE81380	E-12	GSM2151456	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-12	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-12	Breast Cancer
GSE81380	28249907	E-15	None	SRX1758040	GSE81380	E-15	GSM2151457	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-15	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-15	Breast Cancer
GSE81380	28249907	E-20	None	SRX1758041	GSE81380	E-20	GSM2151458	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-20	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-20	Breast Cancer
GSE81380	28249907	E-24	None	SRX1758042	GSE81380	E-24	GSM2151459	Breast Cancer	Invasive Breast Carcinoma (BRCA)	E-24	AU565(pv) tumour bearing SCID mice treated with Trastuzumab alone (D5W days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	E-24	Breast Cancer
GSE81380	28249907	P-13	None	SRX1758043	GSE81380	P-13	GSM2151460	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-13	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-13	Breast Cancer
GSE81380	28249907	P-4	None	SRX1758044	GSE81380	P-4	GSM2151461	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-4	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-4	Breast Cancer
GSE81380	28249907	P-7	None	SRX1758045	GSE81380	P-7	GSM2151462	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-7	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-7	Breast Cancer
GSE81380	28249907	P-8	None	SRX1758046	GSE81380	P-8	GSM2151463	Breast Cancer	Invasive Breast Carcinoma (BRCA)	P-8	AU565(pv) tumour bearing SCID mice treated with Panobinostat alone (Panobinostat 15mg/kg days 0,1; PBS days 0)	Mus musculus	P-8	Breast Cancer
GSE81380	28249907	PE-11	None	SRX1758047	GSE81380	PE-11	GSM2151464	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-11	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-11	Breast Cancer
GSE81380	28249907	PE-16	None	SRX1758048	GSE81380	PE-16	GSM2151465	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-16	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-16	Breast Cancer
GSE81380	28249907	PE-2	None	SRX1758049	GSE81380	PE-2	GSM2151466	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-2	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-2	Breast Cancer
GSE81380	28249907	PE-22	None	SRX1758050	GSE81380	PE-22	GSM2151467	Breast Cancer	Invasive Breast Carcinoma (BRCA)	PE-22	AU565(pv) tumour bearing SCID mice treated with Panobinostat + Trastuzumab (Panobinostat 15mg/kg days 0,1; Trastuzumab 10mg/kg days 0)	Mus musculus	PE-22	Breast Cancer
